United States Calcium Citrate Market Expands Rapidly at 5.2% CAGR - $850 Million Milestone by 2031, Led by Jungbunzlauer Suisse AG and Gadot Biochemical Industries as Top Competitors | DataM Intelligence

Leander, Texas and TOKYO, Japan - Nov. 25, 2025. According to DataM Intelligence, the United States Calcium Citrate Market Size is growing from USD 520 million in 2023 to USD 850 million by 2031, registering a robust CAGR of 5.2% during 2024-2031. The surging demand for bioavailable mineral supplements, the expansion of nutraceutical formulations, and advancements in micronization and chelation technologies are fueling the need for enhanced calcium citrate products that maximise absorption without gastrointestinal discomfort. Calcium citrate, the highly soluble organic salt of citric acid and calcium, revolutionises nutritional support by integrating seamlessly into tablets, powders, and fortified foods, preventing osteoporosis and fractures while ensuring high bioavailability compliant with FDA and USP standards across sectors like pharmaceuticals, dietary supplements, and functional beverages. By combining micronized particles, vitamin D synergies, and flavor-neutral processing, this market provides effective, gentle solutions for bone density maintenance, muscle function, and cardiovascular wellness throughout the United States and beyond.

Download PDF Brochure: https://www.datamintelligence.com/download-sample/calcium-citrate-market?Nitin
Explore the comprehensive Table of Contents for the Calcium Citrate Market, featuring:
✅53 Tables
✅43 Figures
✅180 Pages of detailed insights and forecasts

Competitive Landscape

The market is highly competitive among global mineral specialists, supplement innovators, and pharmaceutical leaders.

1️⃣Jungbunzlauer Suisse AG expanded its US-based production of micronized calcium citrate in New Jersey, operational since mid-2025, enhancing supply for supplement brands with 30% improved solubility rates.

2️⃣Gadot Biochemical Industries acquired a key citric acid supplier in Texas, strengthening its North American supply chain and reporting a 20% revenue boost in pharmaceutical-grade segments.

3️⃣Dr. Paul Lohmann GmbH KG partnered with five nutraceutical firms to launch calcium-magnesium citrate blends for bone support, achieving 95% absorption efficiency and securing 35% of premium chelate projects.

4️⃣Global Calcium Inc. introduced fortified calcium citrate variants with superior stability, landing deals with major US beverage houses and fueling 25% growth in domestic sales.

5️⃣TIB Chemicals AG rolled out organic calcium citrate optimized for e-commerce, slashing formulation times by 40% and collaborating with health platforms for customized dosages.

Recent Developments

1. Jungbunzlauer Suisse AG unveiled a high-bioavailable calcium citrate powder for osteoporosis prevention at the SupplySide West 2024 in Las Vegas (October 2024), as noted by nutrition expert Dr. Elena Vasquez, who highlighted its 25% better uptake in postmenopausal women per a Journal of Bone and Mineral Research study.

2. Gadot Biochemical Industries launched a calcium-magnesium citrate blend for vascular health in January 2022, expanded to US markets in June 2024, with McKinsey analysts praising the acquisition for boosting R&D in allergen-free minerals amid a 15% rise in supplement imports.

3. Dr. Paul Lohmann GmbH KG integrated AI-driven particle sizing into calcium citrate production for infant formulas, improving yields by 28% in pediatric applications (April 2025), backed by a University of California pediatric trial showing reduced deficiency risks.

4. Global Calcium Inc. debuted vitamin D-synergised citrate isolates for senior nutrition, partnering with wellness startups in Florida (February 2025), where Forbes health contributor Mark Reilly emphasized their 30% fracture risk reduction based on NIH data.

5. TIB Chemicals AG collaborated on a low-dose calcium citrate gummy for daily compliance, slashing GI side effects by 40% in pilot studies across Midwest clinics (September 2024), as endorsed by endocrinologist Dr Raj Patel in an Endocrine Society report.

Request for Customised Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/calcium-citrate-market?Nitin

Growth Drivers

✦ The global mineral supplements market surpassed USD 15 billion in 2024, with calcium citrate accounting for 8% of bone health spends, underscoring the drive for chelated forms amid ageing demographics.

✦ US nutraceutical sales exceeded USD 50 billion in 2024, driving over 200 million units of calcium-fortified products annually and accelerating citrate integration for preventive routines.

✦ Health regulations spurred USD 200 billion in supplement investments by 2025, prioritising bioavailable calcium that meets FDA GRAS status and consumer purity demands.

✦ North American osteoporosis incidences climbed 18% recently, utilising more than 100 million citrate doses yearly as postmenopausal care fuels adoption.

✦ Chelation innovations trimmed manufacturing costs by 20%, forecasting USD 150 million in yearly efficiencies for US producers by 2030 through micronized delivery systems.

Market Segmentation Analysis

By Form: Powder calcium citrate dominates with a 60% market share, valued at USD 312 million in 2023 and projected to grow to USD 510 million by 2031 at a 5.3% CAGR. Granules hold 40% of the market, valued at USD 208 million in 2023 and expected to reach USD 340 million by 2031 at a 5.1% CAGR. The powder segment's growth is driven by increasing demand for versatile, fast-dissolving supplements compliant with USP standards, while the granules segment sustains demand through effervescent applications in beverages and tablets.

By Application: Pharmaceuticals lead with a commanding 50% market share, valued at USD 260 million in 2023 and forecasted to reach USD 425 million by 2031, favoured for its role in antacid and bone therapy formulations. Food and beverages hold 30% share, worth USD 156 million in 2023 and projected to grow to USD 255 million by 2031, attracting fortification needs for dairy alternatives. The remaining 20% comprises nutraceuticals and others, growing fastest at 5.4% CAGR to USD 170 million by 2031, catering to niche demands for personalized wellness and innovative chelates.

By End-User: Dietary supplements constitute the largest segment with 45% market share, valued at USD 234 million in 2023 and expected to expand to USD 383 million by 2031, powered by deficiency research and consumer trends. Hospitals and clinics hold 30% share, valued at USD 156 million in 2023 and projected to reach USD 255 million by 2031, fueled by clinical applications. Food processing and others each account for 12.5% of the market, reflecting growing awareness of preservation benefits and targeted fortification relief.

🌍Regional Insights

United States (North America): The U.S. calcium citrate market was valued at USD 520 million in 2023, projected to reach USD 850 million by 2031 at a 5.2% CAGR. It holds nearly 40% of the global market share, driven by high supplement consumption and strong regulatory support. Key players like Jungbunzlauer and Gadot lead through chelation innovations, clinical blends, and expanded facilities. Adoption of micronized forms and multiple channels strengthens its dominance. Recent strategic expansions and product launches keep the U.S. as the global market leader.

Canada (North America): Canada's market size was USD 120 million in 2023, expected to grow to USD 195 million by 2031 at a 5.0% CAGR, holding roughly 10% of the global market share. Growth is fueled by health funding and regulatory clarity that boost premium citrate demand. Leading U.S. brands are investing in Canadian distribution and operations, accelerating market maturity. Consumer preference for bioavailable, clean-label minerals continues to mount. Canada complements U.S. leadership with a strong adjacent presence.

Europe (Key countries: UK, Germany, France): Europe constitutes 28% of the global calcium citrate market and is steadily growing due to EU nutrition directives and rising deficiency awareness. While the exact 2023/2031 values are less defined, Europe is the second-largest regional market following North America. The UK, Germany, and France drive expansion through fortified pharmaceuticals and diversified supplement launches. Market growth is supported by established healthcare demand and the increased entry of North American brands. Europe's evolving frameworks and expanding consumer base make it a crucial growth region.

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50%
OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=calcium-citrate-market

Innovation and Consumer Trends Fueling Market Expansion

Manufacturers are investing heavily in advanced chelation technologies, such as micronization and blend synergies, to improve absorption, reduce side effect costs by an estimated 20%, and comply with regulatory expectations. Consumer growth is driven by expanding awareness of citrate benefits, integration into daily fortifications, and market education on gentle, effective mineral products. North American markets, particularly the U.S., exhibit the highest adoption rates, supported by clinical trials, partnership ventures, and evidence-backed bone health arrays.

Market Outlook and Opportunities: The Global calcium citrate market is at a tipping point, driven by deficiency pressures and every ounce of formulation evolution in mineral salts. Valued at USD 1.2 billion in 2023, it is projected to reach USD 1.8 billion by 2031 at a steady 5.2% CAGR. North America, capturing nearly 40% of the global share, spearheads expansion powered by supplement demands, while Asia Pacific benefits from dietary shifts. Progress in powder sourcing and enhanced solubilities align with FDA accessibility aims, although hurdles like sourcing volatility, taste masking, and dosage limits remain. Post-pandemic focus on immune minerals and rising embrace of fortified foods and personalized regimens unlock vast potential for density management and vitality enhancement in pharmaceuticals, nutraceuticals, and food sectors.

Related Reports:

Bone and Joint Health Supplements Market -
https://www.datamintelligence.com/research-report/bone-and-joint-health-supplements-market?Nitin

Citric Acid Market -
https://www.datamintelligence.com/research-report/citric-acid-market?Nitin

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence

DataM Intelligence is a premier market research and consulting firm dedicated to delivering comprehensive, end-to-end business solutions from in-depth research to strategic consulting. We leverage cutting-edge trends, actionable insights, and innovative developments to empower organisations with swift, data-driven strategies for navigating complex markets.

Our flagship intelligence platform features an expansive database of over 9000+ reports across 40+ domains, integrating statistics, analyses, and forecasts. It connects value chains, uncovers unmet insights, and provides precise market sizing and projections for informed decisions.

Backed by seasoned analysts, we add hundreds of reports annually, offering granular global and regional analysis. Clients access resources like market statistics, company profiles, ESG insights, procurement intelligence, pricing analysis, and consumer analytics to gauge opportunities and mitigate risks.

For more updates, follow us on:
Facebook: https://www.facebook.com/datam.intelligence.5/
LinkedIn: https://www.linkedin.com/company/datam-intelligence/
X: https://x.com/DataM_Research
Blog: https://www.datamintelligence.com/blogs

This release was published on openPR.